DNA topoisomerase IIα expression in optic pathway gliornas of childhood

被引:10
作者
Bredel, M
Slavc, I
Birner, P
Czech, T
Haberler, C
Ströbel, T
Wolfsberger, S
Budka, H
Hainfellner, JA
机构
[1] Univ Vienna, Inst Neurol, A-1097 Vienna, Austria
[2] Univ Vienna, Dept Pediat, A-1097 Vienna, Austria
[3] Univ Vienna, Inst Clin Pathol, A-1097 Vienna, Austria
[4] Univ Vienna, Dept Neurosurg, A-1097 Vienna, Austria
关键词
epipodophyllotoxins; immunohistochernistry; multidrug resistance; MIB-1 proliferation index; optic pathway gliomas; topoisomerase II alpha;
D O I
10.1016/S0959-8049(01)00387-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DNA topoisomerase IIalpha (Topo IIalpha) is linked to tumour cell growth and chemoresistance. We examined immunohistochemically Topo IIalpha expression levels in a series of 36 consecutive paediatric optic pathway glioma (OPG) patients. Topo IIalpha labelling index (LI) ranged from 0.0 to 11.6 and was significantly associated with patient age, with higher levels of Topo IIalpha in children less than or equal to3 years (P = 0.031). Topo IIalpha expression did not correlate with patient survival. Topo IIalpha LI was not significantly increased in specimens of repeat surgery. Topo IIalpha LI closely correlated with MIB-I LI (R=0.781, P<0.001), We conclude that Topo II alpha expression correlates with tumour cell proliferation in paediatric OPGs. Assessment of cell proliferation. however, does not assist in refining prognostic predictions. Enhanced Topo II alpha expression in children <= 3.0 years suggests that Topo II alpha-interfering anticancer compounds for adjuvant treatment of OPGs may be of particular benefit to young children. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:393 / 400
页数:8
相关论文
共 32 条
[1]  
[Anonymous], 2000, World Health Organisation Classification of Tumours: Pathology and genetics of tumours of the nervous system
[2]   BRAIN-TUMORS WITH SYMPTOMATIC ONSET IN THE FIRST 2 YEARS OF LIFE [J].
BALESTRINI, MR ;
MICHELI, R ;
GIORDANO, L ;
LASIO, G ;
GIOMBINI, S .
CHILDS NERVOUS SYSTEM, 1994, 10 (02) :104-110
[3]   Structure and mechanism of DNA topoisomerase II [J].
Berger, JM ;
Gamblin, SJ ;
Harrison, SC ;
Wang, JC .
NATURE, 1996, 379 (6562) :225-232
[4]  
Brandes AA, 1998, CANCER, V82, P355, DOI 10.1002/(SICI)1097-0142(19980115)82:2<362::AID-CNCR17>3.0.CO
[5]  
2-X
[6]   Etoposide containing regimens with autologous bone marrow transplantation in children with malignant brain tumors [J].
Busca, A ;
Miniero, R ;
Besenzon, L ;
di Montezemolo, LC ;
Cenni, N ;
Fagioli, F ;
Sandri, A ;
Vassallo, E ;
Ricardi, U ;
Madon, E .
CHILDS NERVOUS SYSTEM, 1997, 13 (11-12) :572-577
[7]   Chemotherapy in low-grade astrocytoma management [J].
Castello, MA ;
Schiavetti, A ;
Varrasso, G ;
Clerico, A ;
Cappelli, C .
CHILDS NERVOUS SYSTEM, 1998, 14 (1-2) :6-9
[8]   Recurrent cerebellar gliomas: Salvage therapy with oral etoposide [J].
Chamberlain, MC .
JOURNAL OF CHILD NEUROLOGY, 1997, 12 (03) :200-204
[9]   RETRACTED: RECURRENT CHIASMATIC-HYPOTHALAMIC GLIOMA TREATED WITH ORAL ETOPOSIDE (Retracted article. See vol. 28, pg. 4018, 2010) [J].
CHAMBERLAIN, MC ;
GRAFE, MR .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :2072-2076
[10]   Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis [J].
Cummings, TJ ;
Provenzale, JM ;
Hunter, SB ;
Friedman, AH ;
Klintworth, GK ;
Bigner, SH ;
McLendon, RE .
ACTA NEUROPATHOLOGICA, 2000, 99 (05) :563-570